Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics

investor.lilly.com/news-releases/news-release-details/lilly-expand-its-pain-pipeline-acquisition-siteone-therapeutics

Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics
Transaction will augment Lilly's efforts to advance non-opioid medicines for pain management
The transaction includes STC-004, a Phase 2 ready Nav1.8 inhibitor being studied for the treatment of pain. STC-004 may…

This story appeared on investor.lilly.com, 2025-05-27 17:57:38.224000.
The Entire Business World on a Single Page. Free to Use →